Radiologic changes in infancy in McKusick cartilage hair hypoplasia.

Cartilage hair hypoplasia (CHH), or metaphyseal dysplasia McKusick type, classically comprises short stature and scant fine hair. In this skeletal dysplasia there is a high incidence of immune deficiency and Hirschsprung disease, as well as a higher rate of malignancy. Clinical findings may be subtle in young children, and radiographic changes may be elusive. We present four children below age 2 in whom the clinical diagnosis of CHH was confirmed radiographically. We emphasize radiologically and clinically discernable anterior angulation of the entire sternum, a sign not previously described in this dysplasia.     

Chronic excretion of a norovirus in a child with cartilage hair hypoplasia (CHH).

We have demonstrated the long-term excretion of a stable recombinant norovirus in a patient with cartilage hair hypoplasia (CHH), with a T cell immunodeficiency, following bone marrow transplantation (BMT). The patient excreted an ARG320/1999/US-like recombinant norovirus (rGII-3) for 156 days during a period of immune reconstitution. The child was symptomatic during the period of virus shedding. It is not known if the child acquired the recombinant strain or if recombination occurred in vivo.     

T cell regulation of collagen-induced arthritis in mice. II. Immunomodulation of arthritis by cytotoxic T cell hybridomas specific for type II collagen

Injection of native type II collagen (CII) to susceptible strains of mice (H-2^q) induces a rheumatoid arthritis-like disease. To study the role of CD8⁺ T cells in the collagen-induced arthritis (CIA),we generated CII-specific T cell hybridomas by fusion of cells from arthritic C3H.Q mice and an AKR thymoma. Two hybrid clones (P3G8 and P2D9) were selected for their ability to lyse syngeneic CH-pulsed macrophages and recognize different antigenic epitopes in association with K^q molecules. When these T cell clones were irradiated and inoculated into (C3H.Q × AKR)F₁ mice 21 days prior to priming with native CII/ complete Freund's adjuvant, the incidence and the duration of CIA were significantly reduced in comparison to groups receiving saline or control T cell hybridoma. Furthermore, both anti-CII T cell hybridomas were able to attenuate CIA in highly susceptible inbred strains of mice and this suppression was antigen and disease specific. The protective activity seems to require intact cells as neither membrane fractions nor cytosolic preparations of the hybridoma T cells retained the vaccinating activity. Most importantly, one of the hybrid clones (P3G8) had a therapeutic effect on CIA since its administration to arthritic DBA/1 mice on day 30 after priming down-regulated the ongoing disease. Taken together, these findings suggest that anti-CII cytotoxic T cell clones can vaccinate against CIA and even reverse the disease.     

T cell suppression in vitro. II. Nature of specific suppressive factor

The mechanism of specific T cell suppression in vitro was investigated. It was found that suppression of hapten-reactive B cells only occurred in the presence of hapten linked to the carrier to which the T cells were reacting. Thus, there was the same requirement for linked recognition in T cell suppression as was previously described in cooperation. The nature of the suppressive factor was investigated, and like the cooperating factor, it was found to have specificity for the immunizing carrier protein and to be fully absorbed by peritoneal macrophages. The ratio of helper to suppressor activity obtained from activated T cells did not change between 4 and 8 days after injection of antigen and thymocytes. Both activities were absorbed by Sepharose beads conjugated with polyvalent anti-mouse Ig, anti-? or anti-μ-chain antibody. There was thus a resemblance between the T cell suppressive factor and the immunizing factor, although it is not yet known whether both properties are expressed by one and the same molecule. This must await further biochemical characterization of specific T cell factors.     

Lymphocyte receptors. II. Receptors for rabbit IgM on human T lymphocytes.

Human peripheral blood lymphocytes were found to give an opsonic adherence reaction with IgM-coated erythrocytes. This reactivity could only be detected after incubating the lymphocytes at 37 degrees, was confined to the T-lymphocyte population and could be inhibited by IgM but not IgG. It is concluded that human T lymphocytes possess a receptor for IgM.     

T cell defect in essential mixed cryoglobulinaemia.

Peripheral blood lymphocytes from untreated patients with essential cryoglobulinaemia were studied for their surface markers and for their in vitro mitogenic reactivity. No differences in lymphocyte subpopulations were observed between cryoglobulinaemic patients and normal controls. Cultures of separated lymphocytes were stimulated with different concentrations of phytohaemagglutinin, Con-A and pokeweed mitogen. Incorporation of [3H]-thymidine in patients' cultures was compared with that of normal controls. Significantly decreased reactivity to phytohaemagglutinin and Con-A, but not to pokeweed mitogen, was found in all patients studied. The depressed mitogenic reactivity to phytohaemagglutinin and Con-A might be referred to a qualitative T cell defect.     

Single cell observation of calcium signals in class II specific killer T cells.

A confocal fluorescence microscope with an argon ion laser and a digital imaging fluorescence microscope were used to study calcium signals in class II-specific killer T cells after interaction with target cells. Here, we used two kinds of I-Ak specific allogeneic killer T cell clones, QM11 (CD8+) and QM56 (CD4+), and target cells, B10.A spleen cells (I-Ak) and B cell hybridomas (TP67.21, I-Ak). After interaction with target cells, the intracellular free calcium ion concentration ([Ca2+]i) in QM11 cells (CD8+) increased rapidly with short lag-times (several seconds). The [Ca2+]i in QM56 cells (CD4+), however, increased with much longer lag-times (hundreds of seconds). The results were consistent with previous findings that the cytolytic activity of QM11 cells (CD8+) was much greater than that of QM56 cells (CD4+).     

浓缩生长因子修复兔髁突全层软骨损伤

背景:浓缩生长因子对组织修复有促进作用,目前尚缺乏其对髁突软骨修复影响的研究.目的:研究浓缩生长因子对兔颞下颌关节髁突全层软骨损伤修复的影响.方法:采集兔静脉血制备浓缩生长因子.建立兔双侧髁突穿透软骨下骨皮质的全层软骨损伤模型,实验侧损伤区充填浓缩生长因子,对照侧自然愈合.分别于术后2,6,12周取材并进行组织形态学观...     

Immunolocalization of Wnt5a during the hair cycle and its role in hair shaft growth in mice

Previous studies have shown that the Wnt signaling pathway plays an important role in the growth and development of hair follicles. It has been generally accepted that Wnt5a, a non-canonical Wnt gene, inhibits the Wnt/β-catenin signaling pathway. Several reports have addressed its mRNA expression in embryonic and postnatal hair follicles, but its exact role in the growth of hair follicles is currently unknown. In this study, we investigated the immunolocalization of Wnt5a protein in pelages of the dorsal skin and whisker follicles of mice. We found that in the anagen phase, dermal papilla cells showed the highest staining levels of Wnt5a protein, while in the catagen and the telogen phases the staining levels were lower. During the growth stage, Wnt5a protein was prominently located in the matrix and precortex cells in addition to the inner root sheath, outer root sheath and the dermal papilla. As the hair cycle progresses, the immunostaining of Wnt5a was gradually decreased in the catagen phase and was located in the bulge and secondary hair germ in the telogen phase. This Wnt5a immunostaining profile was consistent between dorsal skin pelages and whisker follicles. Furthermore, in an in vitro study using whisker follicle organ culture, we demonstrated that the growth of the hair shaft was significantly inhibited by adenovirus Wnt5a. Our findings suggest that Wnt5a is a dynamic factor in the hair cycle and it is important for the regulation of hair shaft growth.     

The T cell suppressor defect in autoimmune thyroiditis: evidence for a high set ''autoimmunostat''.

Plasma samples from patients with nephritic factor (NeF) were examined for their C3 converting activity. C3, C3dg, C5 and the fluid phase terminal complement complex (TCC) were quantified. All patients had evidence of C3 activation with low plasma C3 and high C3dg. Some patients had normal C5 and normal TCC levels, and thus no evidence of terminal pathway activation in vivo; others, with slower C3 conversion in vitro, had low C5 levels with TCC either elevated or in the upper normal range, suggesting in vivo activation of the terminal pathway. These observations were confirmed by in vitro experiments using purified NeFs. It is concluded that considerable activation of C3 may occur in vivo without a simultaneous activation of the terminal pathway, and that NeF is heterogeneous with regard to its ability to activate complement.     

Peripheral tolerance in T cell receptor-transgenic mice: Evidence for T cell anergy

T cell tolerance can be induced in adult mice by injection of soluble antigenic peptide. The underlying mechanism has been difficult to establish in normal mice due to the low precursor frequency of T cells specific for any given antigen. Therefore, we examined peripheral tolerance in mice transgenic for a T cell receptor specific for a cytochrome c peptide bound to I-E^k. Antigen-specific hyporesponsiveness could be induced in the transgenic mice. We followed the transgene-bearing T cells with a clonotypic monoclonal antibody and found similar numbers of clonotypic T cells in tolerized and control mice. To prevent de novo differentiation of T cells we analyzed thymectomized mice in which antigen-specific hyporesponsiveness was induced. Our analysis of thymectomized transgenic mice showed that antigen-specific T cell hyporesponsiveness following injection of peptide intravenously is not caused by gross elimination of T cells. These data provide evidence for the role of anergy in peripheral tolerance.     

Adenosine deaminase activity during the growth cycle of T and B lymphoid cell lines.

Adenosine deaminase activity per cell was constant during the growth of B cells but increased during logarithmic growth of T cells and decreased as T cell viability decreased during the stationary phase of growth. This elevated enzyme activity appears to be a biochemical marker for T cell leukemic blasts.     

Evidence that X-linked severe combined immunodeficiency is not a differentiation defect of T lymphocytes.

In order to gain information about the nature of the defect in X-linked severe combined immunodeficiency (XSCID), we investigated gene expression in different lymphoid and haematopoietic cells of female carriers by looking for non-random X chromosome usage. We have shown non-random X chromosome usage in T lymphocyte enriched (E+) fraction in all carriers. E- cells and monocytes showed non-random X chromosome usage in three carriers tested. In the B cell series one carrier showed non-random inactivation in all EBV lines tested (10) and the same X chromosome was shown to be active in all cells. In other carriers there was a preference for use of the normal X chromosome but some B cell lines used the mutant X as well as the normal X. Similar results were found with granulocytes. In two female carriers DNA made directly from whole blood showed a non-random pattern of X chromosome usage. In fibroblast cultures from two female carriers more cells had the normal gene on the active X chromosome than had the defective gene on the active X chromosome. Within families there was heterogeneous expression of the gene. The gene that is defective in XSCID is expressed in all the cell types studied and, therefore, is not a T lymphocyte differentiation gene. The results are consistent with the gene being in a metabolic pathway as in certain autosomal recessive forms of SCID i.e. adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency.     

Characterization of a monoclonal IgA rheumatoid factor. II. Evidence for reactivity with a specific IgG Fc fragment determinant

Evidence is provided which supports the concept that a previously characterized monoclonal IgA-λ rheumatoid factor with a medium-binding avidity reacts with a select Fc region antigenic determinant. The interaction between this rheumatoid factor and anti-Rh-coated human erythrocytes is inhibited by IgG1 Fc fragment, IgG1 heavy chains, and a single peptide pool isolated from this tryptic digest by paper chromatography. Cyanogen bromide cleavage of the isolated heavy chains abolishes this reactivity. A methionine residue is assumed to be near, involved in, or necessary for reactivity between the IgA and its antigenic determinant. The data thus provide further evidence for a specific autoantigenic, rheumatoid factor-reactive determinant.     

Evidence for T cell receptor-HLA class II molecule interaction in the response to superantigenic bacterial toxins

The staphylococcal enterotoxins and related microbial T cell mitogens stimulate T cells by cross-linking variable parts of the T cell receptor (TcR) with MHC class II molecules on accessory or target cells. In this report we describe that a given combination of T cell, accessory cell (AC) and toxin can be non-stimulatory. However, the same T cell can respond to the same toxin on another AC and the same AC can present the same toxin to another T cell. This indicates that in the complex formed between TcR, toxin and class II molecule an interaction between TcR and class II molecule takes place.     

Lymphocyte activation in human ageing: V. Acquisition of response to T cell growth factor and production of growth factors by mitogen-stimulated lymphocytes

In order to ascertain why the T cell proliferative response declines with ageing, the age-related quality of the interleukin II (Il-2)-mediated signal during lymphocyte activation was investigated in mitogen-stimulated peripheral blood mononuclear cells (PBMC) from old (over 70 years) and adult (20-40 years) subjects. Both the Il-2 properties of supernatants produced by phytohaemagglutinin (PHA)-stimulated PBMC on Il-2 sensitive cells and the PHA-induced transformation in Il-2 sensitive T cells were decreased in the old subjects. Supplements with human Il-2 enhanced the DNA synthesis by PHA-, concanavalin-A-, or pokeweed-mitogen-activated lymphocytes in the two groups of subjects. The addition of Il-2 to old cultures restored a response similar to that observed in adults cells cultured without exogenous Il-2. The similarity of the dose-response curves to interleukin II indicated the unaltered affinity of the specific membrane receptors to the humoral factors. These findings strongly suggest that the immune deficiency commonly found in the elderly results principally from a selective alteration of the hormonal step of lymphocyte activation.     

Evidence for a defect in "switch" T cells in patients with immunodeficiency and hyperimmunoglobulinemia M

Immunodeficiency with hyperimmunoglobulinemia M is a syndrome characterized by normal to elevated serum levels of IgM and low levels or absence of IgG and IgA. The defect in this syndrome is thought to reside within the B lymphocyte, which may be unable to undergo a "switch" in immunoglobulin class from IgM to IgG or IgA. To address this question more directly, we cultured B cells from nine patients with this syndrome with pokeweed mitogen and either "switch" T cells or normal control T cells. In cultures with normal T cells, only IgM was secreted, whereas in cultures with switch T cells, IgG as well as IgM, or IgM, IgG, and IgA were secreted. Furthermore, analysis of the immunoglobulin heavy-chain genes in these B cells by means of genetic probes of constant and switch regions revealed normal gene patterns. These data suggest that B cells from patients with hyperimmunoglobulinemia M may not be abnormal, as previously proposed, and that, at least in some patients with this syndrome, a defect in switch T cells may be pathogenic.